Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1984 Sep;20(3):330–333. doi: 10.1128/jcm.20.3.330-333.1984

Use of 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan as a primary medium for recovery of Pseudomonas aeruginosa from clinical specimens.

G F Araj
PMCID: PMC271323  PMID: 6436302

Abstract

Several concentrations of 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan (C-390), ranging from 5 to 100 micrograms/ml, were incorporated in brain heart infusion agar, MacConkey agar, and xylose-lysine-deoxycholate agar to evaluate the recovery of Pseudomonas aeruginosa from 538 sputum, 174 urine, and 22 stool samples. Seventy-six sputum samples containing P. aeruginosa grew this bacterium alone on brain heart infusion and MacConkey agars with a C-390 concentration of 25 micrograms/ml or greater. Other microorganisms present in these specimens grew only on media without C-390, and significantly less growth was observed on media with less than 20 micrograms of C-390 per ml. In few samples containing Klebsiella pneumoniae (3 of 30) and Serratia spp. (3 of 10), these organisms grew on all C-390 media and concentrations tested. The remaining sputum samples grew other bacteria and yeasts only on media without C-390. Brain heart infusion and MacConkey agars with C-390 were equally effective in recovering P. aeruginosa and suppressing the growth of a wide range of bacteria and yeasts from urine and stool samples. Xylose-lysine-deoxycholate agar with C-390 did not show a selective or suppressive advantage over xylose-lysine-deoxycholate agar alone for recovering P. aeruginosa from stool specimens. These results indicate that use of the correct medium and C-390 concentration would provide a suitable primary medium for inhibiting a wide range of bacteria and yeasts and would select the growth of P. aeruginosa from clinical specimens.

Full text

PDF
330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis J. R., Stager C. E., Araj G. F. 4-h Identification of Pseudomonas aeruginosa with 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan. J Clin Microbiol. 1983 Jun;17(6):1054–1056. doi: 10.1128/jcm.17.6.1054-1056.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hart A., Moore K. E., Tall D. A comparison of the British Pharmacopoeia (1973) and United States Pharmacopeia (1975) methods for detecting pseudomonads. J Appl Bacteriol. 1976 Oct;41(2):235–242. doi: 10.1111/j.1365-2672.1976.tb00624.x. [DOI] [PubMed] [Google Scholar]
  3. Lambe D. W., Jr, Stewart P. Evaluation of Pseudosel agar as an aid in the identification of Pseudomonas aeruginosa. Appl Microbiol. 1972 Feb;23(2):377–381. doi: 10.1128/am.23.2.377-381.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Marold L. M., Freedman R., Chamberlain R. E., Miyashiro J. J. New selective agent for isolation of Pseudomonas aeruginosa. Appl Environ Microbiol. 1981 Apr;41(4):977–980. doi: 10.1128/aem.41.4.977-980.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mathewson J. J., Simpson R. B. Glucose-nonfermenting Gram-negative bacilli associated with clinical veterinary specimens. J Clin Microbiol. 1982 Jun;15(6):1016–1018. doi: 10.1128/jcm.15.6.1016-1018.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES